mitochondrial therapy

WALTHAM, Mass. — March 11, 2026 Pretzel Therapeutics announced new preclinical data for its lead therapeutic candidate PX578 during...

NEEDHAM, Mass., September 19, 2025 – Stealth BioTherapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA)...